Department of Biotechnology
Molecular Biotechnology
 Home | Organization | Staff  | Research | Core facilities | Courses | Directions | Links | Intranet

 

Amelie Eriksson Karlström, PhD

School of Biotechnology, KTH
AlbaNova University Center
SE-106 91 Stockholm
Sweden

Email:
Phone: +46-8-5537 8333
Fax: +46-8-5537 8481

Bibliography
Research

Short Biography

Amelie Eriksson Karlström received her PhD in 1997 at the Stockholm University, Department of Neurochemistry and Neurotoxicology, after graduate studies on solid phase peptide synthesis methodology. This was followed by postdoctoral studies 1997-1999 at the Scripps Research Institute, La Jolla, CA, where she was working on catalytic antibodies and display technologies, with the objective of selecting new functional catalyst and investigating the catalytic mechanism of selected antibodies. Amelie Eriksson Karlström is presently Associate Professor in Molecular Biotechnology at the Royal Institute of Technology (KTH), School of Biotechnology, where her research group is working on chemical protein engineering for in vivo and in vitro diagnostic applications, using a combination of chemical synthesis and recombinant technologies. She is also the Director of the “AlbaNova VINN Excellence Centre for Protein Technology (ProNova)“ (www.biotech.kth.se/pronova).

Research group: Nima Jokilaakso (PhD student), Joel Lindgren (PhD student), Anna Perols (PhD student), Daniel Rosik (PhD student) and Kristina Westerlund (PostDoc)

Teaching: Amelie Eriksson Karlström is responsible for the undergraduate course “Drug Development”, which is given in the 4th year of the Biotechnology program at KTH.

Last updated: 2012-06-13